Allergy and Immunology · Hattiesburg, MS
NPI
1518164490
Since 2007
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
109 Millsaps Dr Ste C
Hattiesburg, MS, 39402
Phone (601) 268-5051
Groups this clinician bills Medicare through
Medicare paid, 2024
$574K
28,703 services
Medicare patients, 2024
236
Average age 73
Drug cost, 2024
$1.2M
2,496 prescriptions
Company payments, 2025
$1,930
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathryn L McMullan was code 95165 (treatment - miscellaneous), 2,150 times for 45 patients. In total Kathryn L McMullan billed 28,703 services in 41 codes, and Medicare paid $574K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 2,150 | 45 | $9.10 | $20K |
| 95117 Treatment - Miscellaneous | Office | 884 | 46 | $7.46 | $6,591 |
| 99214 Office E&M - Established | Office | 395 | 204 | $82.47 | $33K |
| 94010 Pulmonary Function Testing | Office | 241 | 136 | $17.31 | $4,172 |
| 95115 Treatment - Miscellaneous | Office | 206 | 17 | $6.30 | $1,297 |
| 96372 Injection Administration | Office | 205 | 21 | $10.01 | $2,051 |
| 99213 Office E&M - Established | Office | 41 | 36 | $58.88 | $2,414 |
| 99204 Office E&M - New | Office | 37 | 37 | $114.27 | $4,228 |
| G0008 Administration of influenza virus vaccine | Office | 15 | 15 | $29.46 | $442 |
| 90661 Vaccine Product | Office | 15 | 15 | $33.70 | $506 |
By year: 2022 $79K for 4,434 services; 2023 $440K for 19,996 services; 2024 $574K for 28,703 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathryn L McMullan prescribed most often to Medicare patients was Azelastine Hcl, with 392 prescriptions and refills. In total Kathryn L McMullan wrote 2,496 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 392 | 647 | 164 | $13K |
| Fluticasone Propionate Generic | 350 | 693 | 135 | $5,703 |
| Montelukast Sodium Generic | 315 | 727 | 85 | $2,892 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 190 | 287 | 35 | $179K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 167 | 182 | 81 | $4,913 |
| Ipratropium Bromide Generic | 165 | 208 | 68 | $6,888 |
| Prednisone Generic | 107 | 107 | 70 | $176 |
| Famotidine Generic | 101 | 196 | 36 | $948 |
| Symbicort Budesonide/Formoterol Fumarate | 64 | 104 | 19 | $23K |
| Advair Hfa Fluticasone Propion/Salmeterol | 49 | 65 | 14 | $19K |
| Doxycycline Hyclate Generic | 49 | 49 | 32 | $334 |
| Spiriva Respimat Tiotropium Bromide | 43 | 57 | 12 | $29K |
| Epinephrine Generic | 40 | 52 | 32 | $8,500 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 36 | 36 | 22 | $357 |
| Azithromycin Generic | 36 | 36 | 25 | $254 |
Brand drugs: 640 claims; generic drugs: 1,856 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathryn L McMullan $1,930 ($1,930 in general payments such as food, travel and fees) from 13 companies. The largest payer was GlaxoSmithKline, LLC. with $446.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 24 | $446 |
| Regeneron Healthcare Solutions, Inc. REGN | 19 | $435 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $314 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $275 |
| Ionis Pharmaceuticals, Inc. IONS | 4 | $99.97 |
| CSL Behring CSL.AX | 4 | $97.5 |
| Octapharma USA, Inc. | 3 | $52.98 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 2 | $52.86 |
| Genentech USA, Inc. ROG.SW | 2 | $41.45 |
| Azurity Pharmaceuticals, Inc. | 2 | $32.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.